We offer both comprehensive bone marrow assessment and comprehensive blood assessment for hematolymphoid malignancies and disorders, including a case summary report integrating professional pathology interpretation and result findings from morphology.
Applied Diagnostics offers a one page summary report that clearly integrates and correlates the findings of all testing performed. Appropriate assays are selected under the guidance and supervision of the pathologist assigned to the case; ensuring continuity and consistency of interpretation.
Methodologies used in comprehensive assessments include:
Our extensive experience in using IHC automation provides you with improved consistency and quality of slides, optimized antibody performance, and quicker processing for immediate review.
Our 10-color flow improves patient care with improved specimen processing even with suboptimal quantity or viability, higher precision in characterizing events, and delivery of faster results.
Upon arrival, all specimens are immediately setup for peer-reviewed cytogentics processing. Our advanced operational protocols ensure viability, maximize cell growth, and improve turnaround times.
We offer an extensive library of validated panels as well as the ability to custom design panels to meet your clinical needs. Our techniques provide cleaner suspension and optimal hybridization.
From initial diagnosis to therapy selection, we provide physicians with integrated diagnostics including comprehensive genetic profiling, bidirectional sequencing, and on-going monitoring of translocations and/or gene expressions.
- qPCR - quantitative Polymerase Chain Reaction
- Sanger– Bidirectional Sequencing
- Next-Gen Sequencing
Our goal is to support your strategy for delivering personalized healthcare that benefits patient outcomes.
Comprehensive bone marrow and blood test offering
|Bone Marrow||Immunohistochemistry and special stains, flow cytometry, fluorescence in situ hybridization (FISH), cytogenetics, array comparative genomic hybridization (aCGH), and/or molecular genetics, including PCR, Pyrosequencing, Sanger Sequencing and Next Generation Sequencing (NGS), as deemed medically necessary by Applied Diagnostics’ hematopathologists and in consultation with the referring physician.|
|Blood||Special stains, flow cytometry, fluorescence in situ hybridization (FISH), cytogenetics, array comparative genomic hybridization (aCGH), and molecular genetics, including PCR, Pyrosequencing, Sanger Sequencing, and Next Generation Sequencing (NGS), as deemed medically necessary by Applied Diagnostics’ hematopathologists and in consultation with the referring physician.|
To view more detailed information, please access our website using your desktop, laptop, or large tablet.
How can we help?
Information for physicians and medical staffGet more info
New & Known
What’s happening in oncologyLearn more
Be a part of helping us to save livesStart helping today